M A Riedl - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

M A Riedl

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Zeitschrift Fur Stomatologie (1984)|October 1, 1989

[Effectiveness of power toothbrushes]C Tscharre-Zachhuber, M A Riedl, S Kulmer, et al.

Allergy|March 29, 2014

Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working GroupM Cicardi, W Aberer, A Banerji, et al.

Allergy|April 25, 2018

Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: The OPuS-2 studyM A Riedl, E Aygören-Pürsün, J Baker, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Zeitschrift Fur Stomatologie (1984)|October 1, 1989

[Effectiveness of power toothbrushes]C Tscharre-Zachhuber, M A Riedl, S Kulmer, et al.

Allergy|March 29, 2014

Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working GroupM Cicardi, W Aberer, A Banerji, et al.

Allergy|April 25, 2018

Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: The OPuS-2 studyM A Riedl, E Aygören-Pürsün, J Baker, et al.

Pageof 1